Founder & Former Owner, Gland Pharma
Parami Partners is backed by Dr. Ravi Penmetsa, founder of Gland Pharma — one of India’s leading B2B sterile injectables businesses, listed on Indian stock exchanges. Dr. Penmetsa built, scaled, and successfully exited Gland Pharma, and is now deploying his capital, networks, and deep sector conviction as a strategic sponsor and investor in Parami Partners.
Managing Partner
Dr. Vishy Chebrol is a seasoned healthcare investor and operator with deep experience in injectables and pharmaceutical platforms. He currently serves as CEO of Sagent Pharmaceuticals, where he is leading the company’s transformation following its acquisition in 2023. His experience spans control investing, platform building, and operational transformation across global regulated markets — combining the credibility of an operator with the rigour of an investor.
Parami Partners is a healthcare-focused private equity platform led by experienced operators and investors with deep expertise in injectables, formulations, and vaccines.
We specialize in acquiring and transforming complex pharmaceutical manufacturing businesses through a hands-on operating approach. Our team has lived inside pharmaceutical platforms — building capacity, navigating regulatory complexity, and driving commercial growth — giving us insight that no spreadsheet can replicate.
Our base is in Hyderabad, India — one of the world’s most important pharmaceutical manufacturing hubs — and we operate with a global perspective, targeting regulated markets in the U.S., Europe, and beyond.
The firm draws on a strong legacy of building and operating platforms across
Sterile manufacturing for regulated market formularies
Complex oral, topical, and specialty formulations for global regulated markets
WHO prequalification, technology transfers, fill-finish capabilities
Our experience spans global regulated markets, with a track record of scaling manufacturing platforms, executing acquisitions, and driving operational excellence.
